PDF(Sci-hub)
Abstract：
The objective was to prepare guidelines to perform the current optimum treatment by organizing effective and efficient treatments of hemangiomas and vascular malformations, confirming the safety, and systematizing treatment, employing evidence-based medicine (EBM) techniques and aimed at improvement of the outcomes. Clinical questions (CQs) were decided based on the important clinical issues. For document retrieval, key words for literature searches were set for each CQ and literature published from 1980 to the end of September 2014 was searched in Pubmed, Cochrane Library, and Japana Centra Revuo Medicina (JCRM). The strengths of evidence and recommendations acquired by systematic reviews were determined following the Medical Information Network Distribution System (MINDS) technique. A total of 33 CQs were used to compile recommendations and the subjects included efficacy of resection, sclerotherapy/embolization, drug therapy, laser therapy, radiotherapy, and other conservative treatment, differences in appropriate treatment due to the location of lesions and among symptoms, appropriate timing of treatment and tests, and pathological diagnosis deciding the diagnosis. Thus, the Japanese Clinical Practice Guidelines for Vascular Anomalies 2017 have been prepared as the evidence-based guidelines for the management of vascular anomalies.
摘要：
目的是通过组织血管瘤和血管畸形的有效和有效的治疗来制定指南，以执行当前的最佳治疗方法。确认安全,系统化治疗，采用循证医学（EBM）技术，旨在改善结果。临床问题（CQ）是根据重要的临床问题决定的。对于文档检索，为每个CQ设置了文献检索的关键词，并在Pubmed中检索了1980年至2014年9月底发表的文献，科克伦图书馆,和JapanaCentraRevuoMedicina(JCRM)。根据医学信息网络分发系统（MINDS）技术确定了通过系统评价获得的证据和建议的优势。总共使用33个CQ来编制建议，受试者包括切除的功效，硬化疗法/栓塞,药物治疗,激光治疗,放射治疗,和其他保守治疗，由于病变的位置和症状之间的适当治疗差异，适当的治疗和测试时机，病理诊断决定诊断。因此，已编制《日本血管异常临床实践指南2017》,作为血管异常治疗的循证指南.
